Trump officials ask US health agencies to pause external communications, Washington Post reports

Published 01/21/2025, 07:30 PM
Updated 01/21/2025, 08:06 PM
© Reuters. FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo

WASHINGTON (Reuters) -The administration of U.S. President Donald Trump has instructed federal health agencies to pause all external communications, such as health advisories, weekly scientific reports, updates to websites and social media posts, the Washington Post reported on Tuesday, citing a dozen current and former officials and sources.

The instructions were delivered on Tuesday to staff at agencies inside the Department of Health and Human Services, including officials at the Food and Drug Administration, the Centers for Disease Control and Prevention, and National Institutes of Health, the newspaper reported. The agencies had no immediate comment.

Trump took office on Monday.

The Washington Post said that it was not clear from the guidance given by the new administration whether the directive would affect more urgent communications, such as foodborne disease outbreaks, drug approvals and new bird flu cases.

Stefanie Spear, a Department of Health deputy chief of staff, instructed agency staff on Tuesday morning to pause external communications, the newspaper reported.

Some officials cited by the newspaper were quoted as saying that the move is aimed at helping newly installed Trump health officials understand the vast flow of information coming out of health agencies.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.